RAMAT GAN, Israel, May 23, 2017 /PRNewswire/ --
EarlySense, the market leader
"As we continue to expand our product offerings and support more health teams around the globe, we've also been diligently working to advance and unify our core software," said Avner Halperin, CEO of EarlySense. "Continuous monitoring of patients in non-acute hospital areas supports the new ECRI safety guidelines by assisting clinical staff in early detection of patient deterioration and potentially adverse events. The update also provides greater flexibility for managing multiple EarlySense systems between divisions or floors, depending on the patient's acuity level."
Earlier this year, the ECRI Institute published its top 10 patient safety concerns for 2017, including unrecognized patient deterioration and opioid administration and monitoring in acute care. EarlySense addresses these concerns through continuously monitoring heart rate, respiratory rate and motion, to aid with early detection and empower clinicians to intervene more effectively. EarlySense technology has proven to assist clinicians in preventing adverse events, reducing of hospital length of stay and saving lives.
The new release provides health teams with expanded remote access to real-time patient data via tablets, computers, laptops and other mobile devices, enabling greater flexibility when monitoring patients and changes in vital signs.
"In this version, we responded to multiple customer requests for enhanced, tablet-based remote view and control of our system and delivered a secure solution that enables clinical teams and leaders to effectively manage our system on the go - wherever they are," added Guy Meger, CTO and VP R&D at EarlySense.
Health facilities with diverse monitoring needs will now be able to manage several EarlySense systems on one central platform. EarlySense systems supported by the new platform include the All-In-One, Safety and Vitals Solutions, with bedside monitors, in addition to InSight, featuring a discrete interface originally designed for post-acute care settings, including skilled nursing and rehabilitation facilities.
EarlySense provides contact-free, continuous monitoring solutions for the medical and consumer digital health markets. EarlySense's patented sensor and advanced algorithms monitor and analyze cardiac, respiratory and motion parameters. Used in hospitals and healthcare facilities worldwide, EarlySense assists clinicians in early detection of patient deterioration, helping to prevent adverse events, including code blues, preventable ICU transfers, patient falls and pressure ulcers.
LIVE by EarlySense is the first home health and sleep monitor powered by medically-proven, contact-free, continuous monitoring technology. The company's OEM technology is also at the core of wellness and sleep products marketed by international partners including Samsung, Beurer and iFit. EarlySense was founded in 2004 and has offices in Waltham, MA, and Ramat Gan, Israel.
For more information, please visit http://www.earlysense.com and http://www.livebyearlysense.com.
Follow EarlySense on LinkedIn, Twitter and Facebook.
Follow LIVE by EarlySense on Facebook and Twitter.
Media Contact: Ellie Hanson Finn Partners +1-929-222-8006 [email protected] Twitter: @elliesheva Company Contact: Hila Peleg EarlySense Marcom Manager +972-54-527-3117 [email protected] Twitter: @EarlySense_Ltd
Subscribe to our Free Newsletters!
Erythropoietin is a hormone secreted by kidneys in response to low oxygen levels in tissues ...
Local anesthesia is a type of anesthesia generally used to block pain sensation only in a specific ...
Sea food allergy is the adverse response of the body''s immune system to the proteins present in ...View All